HY-103186-5mg
|
MedChemexpress LLC
|
MRS-1706 [CAS 264622-53-9]
|
|
COVID-19-immunoregulation
|
|
HY-103186-50mg
|
MedChemexpress LLC
|
MRS-1706 [CAS 264622-53-9]
|
|
COVID-19-immunoregulation
|
|
HY-103186-1mL
|
MedChemexpress LLC
|
MRS-1706 [CAS 264622-53-9] (10mM in DMSO)
|
|
COVID-19-immunoregulation
|
|
HY-110202-1mg
|
MedChemexpress LLC
|
MRS5698 [CAS 1377273-00-1]
|
|
COVID-19-immunoregulation
|
|
HY-13018-10mg
|
MedChemexpress LLC
|
MRT67307 [CAS 1190378-57-4]
|
|
COVID-19-immunoregulation
|
|
HY-13018-100mg
|
MedChemexpress LLC
|
MRT67307 [CAS 1190378-57-4]
|
|
COVID-19-immunoregulation
|
|
HY-13018-5mg
|
MedChemexpress LLC
|
MRT67307 [CAS 1190378-57-4]
|
|
COVID-19-immunoregulation
|
|
HY-13018-50mg
|
MedChemexpress LLC
|
MRT67307 [CAS 1190378-57-4]
|
|
COVID-19-immunoregulation
|
|
HY-13018-1mL
|
MedChemexpress LLC
|
MRT67307 [CAS 1190378-57-4] (10mM in DMSO)
|
|
COVID-19-immunoregulation
|
|
HY-120000-10mg
|
MedChemexpress LLC
|
MS402 [CAS 1672684-68-2]
|
|
COVID-19-immunoregulation
|
|
HY-120000-100mg
|
MedChemexpress LLC
|
MS402 [CAS 1672684-68-2]
|
|
COVID-19-immunoregulation
|
|
HY-120000-25mg
|
MedChemexpress LLC
|
MS402 [CAS 1672684-68-2]
|
|
COVID-19-immunoregulation
|
|
HY-120000-5mg
|
MedChemexpress LLC
|
MS402 [CAS 1672684-68-2]
|
|
COVID-19-immunoregulation
|
|
HY-120000-50mg
|
MedChemexpress LLC
|
MS402 [CAS 1672684-68-2]
|
|
COVID-19-immunoregulation
|
|
HY-120000-1mL
|
MedChemexpress LLC
|
MS402 [CAS 1672684-68-2] (10mM in DMSO)
|
|
COVID-19-immunoregulation
|
|
HY-101854-10mg
|
MedChemexpress LLC
|
N6-(2-Phenylethyl)adenosine [CAS 20125-39-7]
|
|
COVID-19-immunoregulation
|
|
HY-101854-100mg
|
MedChemexpress LLC
|
N6-(2-Phenylethyl)adenosine [CAS 20125-39-7]
|
|
COVID-19-immunoregulation
|
|
HY-101854-200mg
|
MedChemexpress LLC
|
N6-(2-Phenylethyl)adenosine [CAS 20125-39-7]
|
|
COVID-19-immunoregulation
|
|
HY-101854-5mg
|
MedChemexpress LLC
|
N6-(2-Phenylethyl)adenosine [CAS 20125-39-7]
|
|
COVID-19-immunoregulation
|
|
HY-101854-50mg
|
MedChemexpress LLC
|
N6-(2-Phenylethyl)adenosine [CAS 20125-39-7]
|
|
COVID-19-immunoregulation
|
|
HY-101854-1mL
|
MedChemexpress LLC
|
N6-(2-Phenylethyl)adenosine [CAS 20125-39-7] (10mM in DMSO)
|
|
COVID-19-immunoregulation
|
|
HY-B0391-1g
|
MedChemexpress LLC
|
Naftopidil [CAS 57149-07-2]
|
|
COVID-19-immunoregulation
|
|
HY-B0391-10g
|
MedChemexpress LLC
|
Naftopidil [CAS 57149-07-2]
|
|
COVID-19-immunoregulation
|
|
HY-B0391-5g
|
MedChemexpress LLC
|
Naftopidil [CAS 57149-07-2]
|
|
COVID-19-immunoregulation
|
|
HY-B0391-500mg
|
MedChemexpress LLC
|
Naftopidil [CAS 57149-07-2]
|
|
COVID-19-immunoregulation
|
|